Discovery of Synergistic Drug Combinations for Colorectal Cancer Driven by Tumor Barcode Derived from Metabolomics “Big Data”

The accumulation of cancer metabolomics data in the past decade provides exceptional opportunities for deeper investigations into cancer metabolism. However, integrating a large amount of heterogeneous metabolomics data to draw a full picture of the metabolic reprogramming and to discover oncometabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Bo, Xu, Ruijie, Xing, Xinrui, Liao, Chuyao, Zhang, Zunjian, Zhang, Pei, Xu, Fengguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227693/
https://www.ncbi.nlm.nih.gov/pubmed/35736427
http://dx.doi.org/10.3390/metabo12060494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227693/
https://www.ncbi.nlm.nih.gov/pubmed/35736427
http://dx.doi.org/10.3390/metabo12060494

Ejemplares similares